Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs
Dr. Luthman’s experience during the last two decades includes a series of roles leading regulatory affairs teams and strategies for pharmaceutical products spanning from early development to post-approval marketing. Throughout her career, Dr. Luthman has held regulatory positions at large global pharmaceutical and biotechnology companies, including Bristol-Meyers Squibb,
“We welcome Desiree to our growing
About
Verona Pharma’s product candidate, RPL554, is a first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound.
Forward-Looking Statements
This press release contains forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements.
These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including, but not limited to, statements regarding advancing our regulatory plans in the U.S. and
These and other important factors under the caption “Risk Factors” in our final prospectus filed with the
For further information, please contact:
Verona Pharma plc | Tel: +44 (0)20 3283 4200 | |
Jan-Anders Karlsson, Chief Executive Officer | info@veronapharma.com | |
FTI Consulting (UK Media and Investor Enquiries) | Tel: +44 (0)20 3727 1000 | |
Simon Conway / Stephanie Cuthbert / | veronapharma@fticonsulting.com | |
Natalie Garland-Collins | ||
ICR, Inc. (US Media and Investor Enquiries) | ||
Darcie Robinson | Tel: +1 203 682 8379 | |
Darcie.Robinson@icrinc.com | ||
Stephanie Carrington | Tel: +1 646 277 1282 | |
Stephanie.Carrington@icrinc.com |